Inform patients using these concomitant medications of the risk of hypoglycemia and educate them on the signs and symptoms of hypoglycemia Acute Kidney Injury Due to Volume Depletion: There have been postmarketing reports of acute kidney injury in some cases requiring hemodialysis, in patients treated with semaglutide
In the SUSTAIN-6 study, participants taking semaglutide lost an average of 14 pounds, while those on metformin alone saw minimal change
In fact, many insurance plans in 2026 are: Excluding weight-loss medications altogether Restricting coverage to diabetes treatment only Requiring strict prior authorizations That means even though Wegovy and Zepbound are FDA-approved for weight loss, they are often not covered for that purpose
A simple rule: If you're going to run today, plan your meals around it
Pricing for Patients without Insurance Coverage for Zepbound Patients whose commercial insurance does not cover Zepbound face higher costs, but the savings card still helps
Non-alcoholic fatty liver disease and obesity: Biochemical metabolic and clinical presentations